![[current-page:title] logo](/sites/default/files/styles/logo/public/default_images/_no-logo.png?itok=8OH0tuUw){kind=logo}
Website
Recent investment activity
Current status
KANDO id: 40201
Corporate information
Registration country
Funding rounds
Investment activity status
Active investor
Selected investments
Displaying 1 - 3 of 3| Company | Profile | Country | Date Sort ascending | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Neurotech Pharmaceuticals Inc (Neurotech Inc) | Cell-based drugs for diseases of the eye. | Series B | |||
|
|
Elixir Pharmaceuticals Inc | N/A | ||||
|
Intarcia Therapeutics Inc | A biopharmaceutical company applying a targeted approach to the acquisition, development and commercialization of novel therapeutic products for the t | N/A |